Novel Therapeutic Strategies for Malignant Salivary Gland Tumors: Lessons Learned from Breast Cancer

Malignant salivary gland tumors (MSGTs) account for 2–6% of all head and neck cancers. Despite the rarity, MSGTs have been of great interest due to a wide variety of pathological features and high metastasis rates resulting in poor prognosis. Surgical resection followed by radiation therapy represen...

Descripción completa

Detalles Bibliográficos
Autores principales: Murase, Ryuichi, Sumida, Tomoki, Ishikawa, Akiko, Murase, Rumi, McAllister, Sean D., Hamakawa, Hiroyuki, Desprez, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227505/
https://www.ncbi.nlm.nih.gov/pubmed/22164169
http://dx.doi.org/10.1155/2011/187623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227505/
https://www.ncbi.nlm.nih.gov/pubmed/22164169
http://dx.doi.org/10.1155/2011/187623

Ejemplares similares